Functional status and survival in patients with chronic obstructive pulmonary disease following pulmonary rehabilitation;Estado funcional y supervivencia de los pacientes con EPOC tras rehabilitación respiratoria

Archivos de Bronconeumologia

Volumn 42, Issue 9, 2006, Pages 434-439

  López Varela, María Victorina ^a,b,d   Anido, Turquesa ^a,b   Larrosa, María ^c,d  

^a Medical Outpatient Clinic   (Uruguay)

^b Miembro de la Asociación Latinoamericana del Tórax ALAT   (Uruguay)

^c CASMU   (Uruguay)

^d Miembro de la ALAT ^*  (Uruguay)

Author keywords

COPD; Pulmonary rehabilitation; Survival predictors

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DYSPNEA; ERGOMETER; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL STATUS; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PULMONARY REHABILITATION; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE; SURVIVAL;

EID: 33750379938     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13092413     Document Type: Article

References (36)

1. Pauwels RA, Buist AS, Carverley PH, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive. Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med. 2001;163:1256-76.
2. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States. Data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2000;160:1683-9.
3. Sobradillo V, Miratvilles M, Gabriel R, Jiménez Ruiz CA, Villasante C, Mase JF, et al. Geographic variations in prevalence and underdiagnosis of COPD. Results of the Ibercorp Multicentre Epidemiological Study. Chest. 2000;118:981-9.
4. Proyecto Latinoamericano de Investigación en Obstrucción Pulmonar (PLATINO). Disponible en: http://host854awn.plugin. com.br/
5. Celli B, MacNee W and committee members. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS-ERS position paper. Eur Respir J. 2004;23:932-46.
6. Killian KJ, Leblanc P, Martin H, Summers E, Jones HL, Campbell EJM. Exercise capacity and ventilatory, circulatory and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis. 1992;146:935-40.
7. American Thoracic Society. European Respiratory Society. Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 1999;159:S1-S28.
8. Montes de Oca M, Torres S, Hernández Y, Romero E, Talamo C. Peripheral skeletal muscles in COPD patients: correlation with pulmonary function and quality of life. Eur Respir J. 2002;20:497S.
9. Decramer M, Gosselink R, Troosterst T, Verschueren M, Evers G. Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J. 1997;10:417-23.
10. Marquis K, Debigaré R, Lacasse Y, Leblanc P, Jobin Y, Carrier G, et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166:809-13.
11. ERS Task Force Position Paper. Selection criteria and programmes of pulmonary rehabilitation and chronic care scientific group of the European Respiratory Society. Eur Respir J. 1997;10:744-57.
12. American Thoracic Society. Pulmonary rehabilitation 1999. Am J Respir Crit Care Med. 1999;159:1666-82.
13. Chronic obstructive pulmonary disease: national clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax. 2004;59 Suppl 1:1-232.
14. Normativa SEPAR. Normativa sobre la rehabilitación respiratoria. Grupo de Trabajo de la SEPAR. Arch Bronconeumol. 2000;26:257.
15. Ries A, Kaplan R, Limberg T, Prewitt L. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med. 1995;122:823-32.
16. Gosselink R. Respiratory rehabilitation: improvement of short and long-term outcome. Eur Respir J. 2002;20:4-5.
17. Salman GF, Mosier MC, Beasley BW, Calkins DR. Rehabilitation for patients with chronic obstructive pulmonary disease. Meta analysis of randomized controlled trials. J Gen Intern Med. 2003;18:213-21.
18. Montes de Oca M, Torres S, Gonzalez Y, Romero E, Hernández N, Tálamo C. Cambios en la tolerancia al ejercicio, calidad de vida relacionada con la salud y características de los músculos periféricos después de 6 semanas de entrenamiento en pacientes con enfermedad obstructiva crónica. Arch Bronconeumol. 2005;41:413-8.
19. Hui KP, Hewitt AB. A simple pulmonary rehabilitation program improves health outcomes and reduces hospital utilization in patients with COPD. Chest. 2003;124:94-7.
20. ATS Statement. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis. 1991;144:1202.
21. ATS Statement. Guidelines for six-minute walk test. Am J Respir Crit Care Med. 2002;166:111.
22. Mahler D, Wells C. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93:580.
23. Ferrer M, Alonso J, Prieto L, Plaza V, Manso E, Marrades R, et al. Validity and reliability of the St. George's Respiratory Questionnaire after adaption to a different language and culture: the Spanish example. Eur Respir J. 1996;9:1160.
24. Celli B, Cote C, Marín S, Casanova C, Montes de Oca M, Méndez R, et al. The body-mass index, airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005-12.
25. Jones PW, Quirk FII, Baveystock CM, et al. A self-complete measure of health status for chronic airflow limitation: the St. George's Respiratory Questionnaire. Am Rev Respir Dis. 1992;145:1321-7.
26. López Varela MV, Jiménez F, Tempone A, Fagúndez K. Disease severity in COPD patients. Eur Respir J. 2003;22 Suppl 45:5775.
27. Wijkstra PJ, Van Altena R, Kraan J, Otten V, Postma DS, Koëler GH. Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home. Eur Respir J. 1994;7:269-73.
28. Ambach W, Chadwick-Straver VM, Wagenaar RC, Von Keimpema ARJ, Kemper MCG. The effects of a community based pulmonary rehabilitation programme on exercise tolerance and quality of life: a randomized controlled trial. Eur Respir J. 1997;10:104-13.
29. Zu Wallack R. Clinical interpretation of health related quality of life outcomes in COPD: application to critical care. Eur Respir Rev. 2002;12:92-7.
30. Gerardi DA, Lovett L, Benoit-Connors ML, Reardon JZ, Zu Wallack RL. Variables related to increased mortality following out-patient pulmonary rehabilitation. Eur Respir J. 1996;9:431-5.
31. Bowen JB, Volto JJ, Thrall RS, Campbell Haggerty MC, Stockdale-Wooley R, Bandyopadhyay T, et al. Functional status and survival following pulmonary rehabilitation. Chest. 2000;118:697-703.
32. Oga T, Nishimura K, Tsukiro M, Soto S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease. Role of exercise capacity and health status. Am J Respir Crit Care Med. 2003;167:544-9.
33. The IPPB Trial Group. Intermittent positive pressure breathing therapy of chronic obstructive pulmonary disease: a clinical trial. Ann Intern Med. 1983;99:612-20.
34. Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli B. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J. 2004;23:28-33.
35. Domingo Salvaney A, Lamarca R, Ferrer M, García Aymerich J, Alonso J, Félez M, et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166:680-5.
36. Landbo C, Prescott E, Lange P, Vestbo J, Almdal T. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160:1856.